Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP001765) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
scFv anti-HBV PreS1/TACE A9
|
|||||
| Synonyms |
scFv PreS1/TACE A9
|
|||||
| Molecular Weight | 30 kDa | |||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Expression System | Escherichia coli BL21 (DE3) | |||||
| Selection Method | Phage display | |||||
| Highest Status | Research | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS057 | [1] , [2] | ||||
| Scaffold Name | scFv | |||||
| Scaffold Class | Antibody fragment | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Large envelope protein | Binder | Hepatitis B virus infection [ICD-11: XN0GA] | Kd: 176 nM | Inje University; University of Cambridge | [1] , [2] | |
| Disintegrin and metalloproteinase domain-containing protein 17 | Binder | Hepatitis B virus infection [ICD-11: XN0GA] | Kd: 90 nM | Inje University; University of Cambridge | [1] , [2] | |
| References |
|---|